Trial intelligence / Profile preview

Efficacy of Bio-Manguinhos Epoetin Alfa vs Industrialized Epoetin in Hemodialysis Patients

NCT01184495Phase 3Completed

Sponsor
Hospital de Clínicas de Porto Alegre
Start
Apr 2008
Primary completion
Dec 2008
Modality
Biologic, rProtein (Recombinant Protein)
01

Overview

A Phase 3 trial of epoetin alfa in anemia of chronic kidney disease (CKD-A), sponsored by Hospital de Clínicas de Porto Alegre. Started Apr 2008; status: completed.

02

Drugs

epoetin alfa
03

Conditions

anemia of chronic kidney disease (CKD-A)

Beyond the preview

Go deeper on NCT01184495.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01184495.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call